Document:

exv10w4

Exhibit 10.4

SECURITIES PURCHASE AND LOAN CONVERSION AGREEMENT

     This SECURITIES PURCHASE AND LOAN CONVERSION AGREEMENT, dated as of April 12, 2010 (this
“Agreement”), is by and between Brookside Technology Holdings Corp., a Florida corporation (the
“Company”), and Vicis Capital Master Fund, a sub-trust of Vicis Capital Series Master Trust, a unit
trust organized and existing under the laws of the Cayman Islands (“Vicis”).

RECITALS:

     A. The Company owes Vicis $1,737,083 (the “Vicis Debt”), which debt is evidenced by that
certain subordinated promissory note in the original principal amount of $1,500,000, dated as of
September 23, 2008, as amended on August 13, 2009 (the “Subordinated Note”).

     B. Vicis desires to invest an additional $3,000,000 in cash in the Company and to convert the
Vicis Debt in exchange for additional shares of the Series A Convertible Preferred Stock of the
Company (the “Series A Preferred Stock”) and a warrant to purchase shares of the Company common
stock (the “Common Stock”), all on the terms set forth herein.

     C. Simultaneously with the forgoing, the Company intends to enter into an amendment with its
senior lender to amend its senior credit facility in the form attached hereto as Exhibit A
(the “Senior Loan Amendment”).

AGREEMENT:

     In consideration of the foregoing recitals and for good and other valuable consideration
hereinafter set forth, the receipt and sufficiency of which are hereby acknowledged, the parties
hereto, intending to be legally bound, hereby agree as follows:

ARTICLE I

PURCHASE AND SALE OF SECURITIES

     1. Purchase and Sale of Series A Preferred Stock. At the Closing (as defined below),
in consideration of the conversion of the Vicis Debt and the payment of $3,000,000 in cash, the
Company shall issue to Vicis 4,737,083 shares of Series A Preferred Stock (the “Acquired Shares”)
and a warrant to purchase up to 473,708,300 shares of Common Stock in the form attached hereto as
Exhibit B (the “Warrant”). Any shares of Common Stock issuable upon conversion of the
Series A Preferred Stock issued pursuant hereto or upon exercise of the Warrant are herein referred
to as the “Conversion Shares;” and the Warrant, the Acquired Shares and the Conversion Shares are
collectively referred to herein as the “Securities.”

     2. Closing. The closing (the “Closing”) of the transactions contemplated by Section 1
above shall take place simultaneously with the closing of the Senior Loan Amendment.

     3. Closing Deliveries. At the Closing, the Company shall deliver or cause to be
delivered to Vicis (a) a certificate in the name of Vicis evidencing the Acquired Shares and (b)
the Warrant. At the Closing, Vicis shall deliver to the Company, for cancellation, the Subordinated
Note and $3,000,000 in cash.

     4. Release. From and after the Closing: (a) the Subordinated Note shall automatically
be deemed to be terminated, satisfied and of no further force and effect; (b) Vicis hereby fully
releases, acquits, and forever discharges the Company and all of its subsidiaries, affiliates,
successors and assigns, together with their respective past and present directors, officers,
shareholders, employees, agents, attorneys and representatives (collectively, the “Released
Parties”) of and from any and all rights, claims, demands, damages, actions, and causes of action,
of any nature whatsoever, whether known or unknown, whether arising at law or in equity, and
whether direct or indirect, which Vicis may have had, may now have, or may hereafter have, against
the Released Parties by reason of any matter, cause, happening or thing arising under the
Subordinated Note, except for any claims involving fraud, willful misconduct, breach of fiduciary
duty or criminal acts by any Released Party; and (c) the Company shall be entitled, and is hereby
authorized, to terminate all liens on its assets filed by Vicis or its affiliates, if any.

34

 

     5. Securities Law Matters. The Company and Vicis are executing and delivering this
Agreement in accordance with and in reliance upon the exemption from securities registration
afforded by Section 4(2) of the U.S. Securities Act of 1933, as amended, and the rules and
regulations promulgated thereunder (the “Securities Act”), including Regulation D (“Regulation D”),
and/or upon such other exemption from the registration requirements of the Securities Act as may be
available with respect to any or all of the investments to be made hereunder.

ARTICLE II

REPRESENTATIONS AND WARRANTIES

     1. Representations and Warranties of the Company. The Company hereby represents and
warrants to Vicis, as of the date hereof and the Closing Date (except as set forth on the Schedule
of Exceptions attached hereto with each numbered Schedule corresponding to the section number
herein), as follows:

          a. Organization, Good Standing and Power. The Company is a corporation duly incorporated,
validly existing and in good standing under the laws of the State of Florida and has the requisite
corporate power to own, lease and operate its properties and assets and to conduct its business as
it is now being conducted. The Company is duly qualified as a foreign corporation to do business
and is in good standing in every jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary except for any jurisdiction(s) (alone or in
the aggregate) in which the failure to be so qualified will not have a Material Adverse Effect. For
the purposes of this Agreement, “Material Adverse Effect” means any material adverse effect on the
business, operations, properties, prospects, or financial condition of the Company and its
Subsidiaries (as defined below) on the transactions contemplated hereby or by the agreements and
instruments to be entered into in connection herewith or any condition, circumstance, or situation
that would prohibit or otherwise materially interfere with the ability of the Company to perform
any of its obligations under this Transaction Documents (defined below) in any material respect.

          b. Authorization; Enforcement. The Company has the requisite corporate power and authority to
enter into and perform this Agreement, the Warrant and each of the other agreements or instruments
entered into by the parties hereto in connection with the transactions contemplated by this
Agreement (collectively, the “Transaction Documents”) and to issue and sell the Securities in
accordance with the terms hereof. The execution, delivery and performance of the Transaction
Documents by the Company and the consummation by it of the transactions contemplated thereby have
been duly and validly authorized by all necessary corporate action, and no further consent or
authorization of the Company, its Board of Directors or stockholders is required. When executed and
delivered by the Company, each of the Transaction Documents shall constitute a valid and binding
obligation of the Company enforceable against the Company in accordance with its terms, except as
such enforceability may be limited by applicable bankruptcy, reorganization, moratorium,
liquidation, conservatorship, receivership or similar laws relating to, or affecting generally the
enforcement of, creditor’s rights and remedies or by other equitable principles of general
application.

          c. Capitalization. The issued and outstanding shares of capital stock of the Company as of the
Closing Date is as set forth on Schedule (II)(1)(c). All of the outstanding shares of the Common
Stock and any other outstanding security of the Company have been duly and validly authorized.
Except for the Securities, or as disclosed in Schedule (II)(1)(c) attached hereto:

               (i) no holder of shares of the Company’s capital stock has any preemptive rights or any other
similar rights or has been granted or holds any liens or encumbrances suffered or permitted by the
Company;

               (ii) there are no outstanding options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities or rights convertible into, or
exercisable or exchangeable for, any shares of capital stock of the Company or any Subsidiary, or
contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or
may become bound to issue additional shares of capital stock of the Company or any Subsidiary or
options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities or rights convertible into, or exercisable or exchangeable for, any
shares of capital stock of the Company or any Subsidiary;

               (iii) there are no outstanding debt securities, notes, credit agreements, credit facilities or
other agreements, documents or instruments evidencing Indebtedness (as defined in Section 1(s)
below) of the Company or any Subsidiary in excess of $100,000 or by which the Company or a
Subsidiary is or may become bound and involves Indebtedness in excess of $100,000;

35

 

               (iv) there are no financing statements securing obligations in any material amounts, either
singly or in the aggregate, filed in connection with the Company or its Subsidiaries;

               (v) there are no agreements or arrangements under which the Company or any Subsidiary is
obligated to register the sale of any of their securities under the Securities Act of 1933, as
amended (the “Securities Act”);

               (vi) there are no outstanding securities or instruments of the Company or any Subsidiary that
contain any redemption or similar provisions, and there are no contracts, commitments,
understandings or arrangements by which the Company or any Subsidiary is or may become bound to
redeem a security of the Company or a Subsidiary;

               (vii) there are no securities or instruments containing antidilution or similar provisions
that will be triggered by the issuance of the Securities; and

               (viii) the Company does not have any stock appreciation rights or “phantom stock” plans or
agreements or any similar plan or agreement.

          d. Subsidiaries. The Company has no subsidiary except as disclosed in Commission Documents (as
defined below) (collectively, the “Subsidiaries”). The Company owns 100% of such Subsidiaries. For
the purposes of this Agreement, “subsidiary” shall mean any corporation or other entity of which at
least a majority of the securities or other ownership interest having ordinary voting power
(absolutely or contingently) for the election of directors or other persons performing similar
functions are at the time owned directly or indirectly by the Company and/or any of its other
Subsidiaries. Each Subsidiary is validly existing and in good standing under the laws of the
jurisdiction in which it is organized, and has all requisite entity power and authority to carry on
its business as now conducted. Each Subsidiary is duly qualified as a foreign corporation to do
business and is in good standing in every jurisdiction in which its ownership of property or the
nature of the business conducted by it makes such qualification necessary, except to the extent
that the failure to be so qualified or be in good standing would not have a Material Adverse
Effect.

          e. Securities Filings. The Common Stock of the Company is currently reported on the OTC
Bulletin Board and is registered pursuant to the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), and the Company has filed all reports, schedules, forms, statements and other
documents required to be filed by it with the Commission pursuant to the reporting requirements of
the Exchange Act (all of the foregoing, including filings incorporated by reference therein, being
referred to herein as the “Commission Documents”). As of their respective dates, the Commission
Documents complied in all material respects with the requirements of the Securities Act and the
Exchange Act and the rules and regulations of the Commission promulgated thereunder, and such
filings when made by the Company do not contain any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading. The financial
statements of the Company included in the Commission Documents comply in all material respects with
applicable accounting requirements and the rules and regulations of the Commission (defined below)
with respect thereto as in effect at the time of filing. Such financial statements have been
prepared in accordance with United States generally accepted accounting principles applied on a
consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such
financial statements or the notes thereto and except that unaudited financial statements may not
contain all footnotes required by GAAP and remain subject to year end adjustments, and fairly
present in all material respects the financial position of the Company and its consolidated
subsidiaries as of and for the dates thereof and the results of operations and cash flows for the
periods then ended, subject, in the case of unaudited statements, to normal year-end audit
adjustments.

          f. Actions Pending. There is no action, suit, claim, investigation, arbitration, alternate
dispute resolution proceeding or other proceeding pending or, to the knowledge of the Company,
threatened against or involving the Company or any of its respective properties or assets, other
than demands and threats made by the prior owners of USVD, notice of which Vicis hereby
acknowledges being made aware of. There are no outstanding orders, judgments, injunctions, awards
or decrees of any court, arbitrator, governmental or regulatory body, or a self regulatory
authority or trading market against the Company or any officers or directors of the Company in
their capacities as such. To the Company’s knowledge, neither the Company nor any Subsidiary, nor
any director or executive officer thereof (in his/her capacity as such), is or, within the last
five years, has been the subject of any action involving a claim of violation of or liability under
federal or state securities laws or a claim of breach of fiduciary duty. To the knowledge of the
Company, there has not been, and there is not pending or threatened in writing, any investigation
by the United States Securities and

36

 

Commission (the “Commission” or “SEC”) involving the Company or any current director or
executive officer of the Company. The Commission has not issued any stop order or other order
suspending the effectiveness of any registration statement filed by the Company under the Exchange
Act or the Securities Act.

          g. Compliance with Law. The business of the Company and the Subsidiaries has been and is
presently being conducted in accordance with all applicable federal, state and local governmental
laws, rules, regulations and ordinances (including, without limitation, rules and regulations of
each governmental and regulatory agency, self regulatory organization and trading market applicable
to the Company or any Subsidiary).

          h. Taxes. The Company has accurately prepared and filed all federal, state and other tax
returns required by law to be filed by it, has paid or made provisions for the payment of all taxes
shown to be due and all additional assessments, and adequate provisions have been and are reflected
in the financial statements of the Company for all current taxes and other charges to which the
Company is subject and which are not currently due and payable. None of the federal income tax
returns of the Company or any Subsidiary have been audited by the Internal Revenue Service. The
Company has no knowledge of any additional assessments, adjustments or contingent tax liability
(whether federal or state) of any nature whatsoever, whether pending or threatened against the
Company for any period, nor of any basis for any such assessment, adjustment or contingency.

          i. Employees. Neither the Company nor any Subsidiary has any collective bargaining
arrangements or agreements covering any of its employees. Except as set forth in Schedule II(1)(i),
no Executive Officer of the Company (as defined in Rule 501(f) of the Securities Act) has notified
the Company that such officer intends to leave the Company or otherwise terminate such officer’s
employment with the Company. No Executive Officer of the Company, to the knowledge of the Company,
is, or is now, in violation of any material term of any employment contract, confidentiality,
disclosure or proprietary information agreement, non-competition agreement, or any other contract
or agreement or any restrictive covenant, and, to the actual knowledge of the Company, the
continued employment of each such executive officer does not subject the Company or any Subsidiary
to any liability with respect to any of the foregoing matters. The Company and each Subsidiary are
in compliance with all federal, state, local and foreign laws and regulations respecting employment
and employment practices, terms and conditions of employment and wages and hours, except where
failure to be in compliance would not, either individually or in the aggregate, reasonably be
expected to result in a Material Adverse Effect.

          j. Public Utility Holding Company Act and Investment Company Act Status. The Company is not a
“holding company” or a “public utility company” as such terms are defined in the Public Utility
Holding Company Act of 1935, as amended. The Company is not, and immediately after receipt of
payment for the Securities will not be, an “investment company,” an “affiliated person” of,
“promoter” for or “principal underwriter” for, or an entity “controlled” by an “investment
company,” within the meaning of the Investment Company Act.

          k. ERISA. No liability to the Pension Benefit Guaranty Corporation has been incurred with
respect to any Plan by the Company which has not been satisfied by the Company. As used in this
section, the term “Plan” shall mean an “employee pension benefit plan” (as defined in Section 3 of
ERISA) which is or has been established or maintained, or to which contributions are or have been
made, by the Company or any Subsidiary or by any trade or business, whether or not incorporated,
which, together with the Company or any Subsidiary, is under common control, as described in
Section 2(b)14(b) or (c) of the Code.

          l. Securities Act of 1933. Based in material part upon the representations herein of Vicis,
the Company has complied and will comply with all applicable federal and state securities laws in
connection with the offer, issuance and sale of the Securities hereunder. Assuming the accuracy of
the representations and warranties in Article IV hereof (and assuming no change in applicable law
and no unlawful distribution of the Securities by Vicis or other Persons), no registration under
the Securities Act is required for the offer and sale of the Securities by the Company to Vicis as
is contemplated hereby. Neither the Company nor anyone acting on its behalf, directly or
indirectly, has or will sell, offer to sell or solicit offers to buy any of the Securities or
similar securities to, or solicit offers with respect thereto from, or enter into any negotiations
relating thereto with, any person, or has taken or will take any action so as to (i) bring the
issuance and sale of any of the Securities under the registration provisions of the Securities Act
and applicable state securities laws, or (b) or (ii) trigger shareholder approval provisions under
the rules or regulations of any trading market., and neither the Company nor any of its affiliates,
nor any person acting on its or their behalf, has engaged in any form of general solicitation or
general advertising (within the meaning of Regulation D under the Securities Act) in connection
with the offer or sale of any of the Securities.

37

 

          m. No Integrated Offering. Neither the Company, nor any of its affiliates, nor any person
acting on its or their behalf, has directly or indirectly made any offers or sales of any security
or solicited any offers to buy any security under circumstances that would cause the offering of
the Securities pursuant to this Agreement to be integrated with prior offerings by the Company for
purposes of the Securities Act, which would prevent the Company from selling the Securities
pursuant to Regulation D and Rule 506 thereof under the Securities Act, or any applicable
exchange-related stockholder approval provisions, nor will the Company or any of its affiliates or
subsidiaries take any action or steps that would cause the offering of the Securities to be
integrated with other offerings.

          n. Issuance of Securities. The Securities to be issued at the Closing have been duly
authorized by all necessary corporate action and, when paid for or issued in accordance with the
terms hereof, the Securities shall be validly issued and outstanding, free and clear of all liens,
encumbrances and rights of refusal of any kind. When the Conversion Shares are issued and paid for
in accordance with the terms of this Agreement, such shares will be duly authorized by all
necessary corporate action and validly issued and outstanding, fully paid and nonassessable, free
and clear of all liens, encumbrances and rights of refusal of any kind and the holders shall be
entitled to all rights accorded to a holder of such security.

          o. No Conflicts. The execution, delivery and performance of the Transaction Documents by the
Company, and the consummation by the Company of the transactions contemplated hereby and thereby,
and the issuance of the Securities as contemplated hereby, do not and will not (i) violate or
conflict with any provision of the Company’s Articles of Incorporation (the “Articles”) or Bylaws
(the “Bylaws”), each as amended to date, or any Subsidiary’s comparable charter documents; (ii)
conflict with, or constitute a default (or an event which with notice or lapse of time or both
would become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any agreement, mortgage, deed of trust, indenture, note, bond, license, lease
agreement, instrument or obligation to which the Company or any of its Subsidiaries is a party or
by which the Company or any of its Subsidiaries’ respective properties or assets are bound; or
(iii) result in a violation of any federal, state, local or foreign statute, rule, regulation,
order, judgment or decree (including federal and state securities laws and regulations and rules
and regulations of any governmental or any regulatory agency, self-regulatory organization, or
trading market) applicable to the Company or any of its Subsidiaries or by which any property or
asset of the Company or any of its Subsidiaries are bound or affected, except, in all cases, for
such conflicts, defaults, terminations, amendments, acceleration, cancellations and violations as
would not, individually or in the aggregate, have a Material Adverse Effect (other than violations
pursuant to clauses (i) or (iii) (with respect to federal and state securities laws)). Neither the
Company nor any of its Subsidiaries is required under federal, state, foreign or local law, rule or
regulation to obtain any consent, authorization or order of, or make any filing or registration
with, any court or governmental agency in order for it to execute, deliver or perform any of its
obligations under the Transaction Documents or issue and sell the Securities in accordance with the
terms hereof (other than any filings, consents and approvals which may be required to be made by
the Company under applicable state and federal securities laws, rules or regulations).

          p. No Violation. Except as set forth in Schedule II(1)(c), neither the Company nor any
Subsidiary (i) is in default under or in violation of (and no event has occurred that has not been
waived that, with notice or lapse of time or both, would result in a default by the Company or any
Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in
default under or that it is in violation of, any indenture, loan or credit agreement or any other
agreement or instrument to which it is a party or by which it or any of its properties is bound,
except such that, individually or in the aggregate, such default(s) and violations(s) would not
have a Material Adverse Effect, (ii) is in violation of any order of any court, arbitrator or
governmental body, or (iii) is in violation of any of the provisions of its certificate or articles
of incorporation, bylaws or other organizational or charter documents.

          q. Dilutive Effect. The Company understands and acknowledges that its obligation to
issue the Conversion Shares upon conversion of the Acquired Shares is absolute and unconditional
regardless of the dilutive effect that such issuance may have on the ownership interests of other
stockholders of the Company.

          r. Placement Agent’s Fees. No brokerage or finder’s fee or commission are or will be
payable to any Person with respect to the transactions contemplated by this Agreement based upon
arrangements made by the Company or any of its affiliates. The Company agrees that it shall be
responsible for the payment of any placement agent’s fees, financial advisory fees, or brokers’
commissions (other than for Persons engaged by Vicis or any of its affiliates) relating to or
arising out of the transactions contemplated hereby. The Company shall pay, and hold Vicis harmless
against, any liability, loss or expense (including, without limitation, reasonable attorney’s fees
and out-of-pocket expenses) arising in connection with any claim for any such fees or commissions.

38

 

          s. Indebtedness and Other Contracts. Except as disclosed in the Commission Documents,
neither the Company nor any Subsidiary (a) has any outstanding Indebtedness (as defined below in
this Section), (b) is a party to any contract, agreement or instrument, the violation of which, or
default under, by any other party to such contract, agreement or instrument would result in a
Material Adverse Effect, (c) is in violation of any term of or in default under any contract,
agreement or instrument relating to any Indebtedness, except where such violations and defaults
would not result, individually or in the aggregate, in a Material Adverse Effect, or (d) is a party
to any contract, agreement or instrument relating to any Indebtedness, the performance of which, in
the judgment of the Company’s officers, has or is expected to have a Material Adverse Effect. For
purposes of this Agreement: (x) “Indebtedness” of any Person means, without duplication (i) all
indebtedness for borrowed money, (ii) all obligations issued, undertaken or assumed as the deferred
purchase price of property or services (other than trade payables entered into in the ordinary
course of business), (iii) all reimbursement or payment obligations with respect to letters of
credit, surety bonds and other similar instruments, (iv) all obligations evidenced by notes, bonds,
debentures or similar instruments, including obligations so evidenced incurred in connection with
the acquisition of property, assets or businesses, (v) all indebtedness created or arising under
any conditional sale or other title retention agreement, or incurred as financing, in either case
with respect to any property or assets acquired with the proceeds of such indebtedness (even though
the rights and remedies of the seller or bank under such agreement in the event of default are
limited to repossession or sale of such property), (vi) all monetary obligations under any leasing
or similar arrangement which, in connection with generally accepted accounting principles,
consistently applied for the periods covered thereby, is classified as a capital lease, (vii) all
indebtedness referred to in clauses (i) through (vi) above secured by (or for which the holder of
such Indebtedness has an existing right, contingent or otherwise, to be secured by) any mortgage,
lien, pledge, change, security interest or other encumbrance upon or in any property or assets
(including accounts and contract rights) owned by any Person, even though the Person which owns
such assets or property has not assumed or become liable for the payment of such indebtedness, and
(viii) all Contingent Obligations in respect of indebtedness or obligations of others of the kinds
referred to in clauses (i) through (vii) above; (y) “Contingent Obligation” means, as to any
Person, any direct or indirect liability, contingent or otherwise, of that Person with respect to
any indebtedness, lease, dividend or other obligation of another Person if the primary purpose or
intent of the Person incurring such liability, or the primary effect thereof, is to provide
assurance to the obligee of such liability that such liability will be paid or discharged, or that
any agreements relating thereto will be complied with, or that the holders of such liability will
be protected (in whole or in part) against loss with respect thereto; and (z) “Person” means an
individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an
unincorporated organization and a government or any department or agency thereof.

          t. Absence of Certain Changes or Developments. Except as disclosed in Schedule
II(1)(t) attached hereto or as disclosed in the Commission Documents or as contemplated herein and
in the Transaction Documents, since December 31, 2008:

          i. there has been no Material Adverse Effect, and no event or circumstance has occurred or
exists with respect to the Company or its businesses, properties, operations or financial
condition, which, under Exchange Act, Securities Act, or rules or regulations of any Trading
Market, requires public disclosure or announcement by the Company but which has not been so
publicly announced or disclosed;

          ii. the Company has not:

               (a) issued any stock, bonds or other corporate securities or any right, options or warrants
with respect thereto, except pursuant to the exercise or conversion of securities outstanding as of
such date;

               (b) borrowed any amount in excess of $250,000 or incurred or become subject to any other
liabilities in excess of $250,000 (absolute or contingent) except current liabilities incurred in
the ordinary course of business which are comparable in nature and amount to the current
liabilities incurred in the ordinary course of business during the comparable portion of its prior
fiscal year, as adjusted to reflect the current nature and volume of the business of the Company;

               (c) discharged or satisfied any Lien or encumbrance in excess of $250,000 or paid any
obligation or liability (absolute or contingent) in excess of $250,000, other than current
liabilities paid in the ordinary course of business and payments of principal and interest under
existing Indebtedness disclosed in the Commission Documents;

39

 

               (d) declared or made any payment or distribution of cash or other property to stockholders
with respect to its stock, or purchased or redeemed, or made any agreements so to purchase or
redeem, any shares of its capital stock, in each case in excess of $50,000 individually or $100,000
in the aggregate;

               (e) sold, assigned or transferred any other tangible assets, or canceled any debts or claims,
in each case in excess of $250,000, except in the ordinary course of business;

               (f) sold, assigned or transferred any patent rights, trademarks, trade names, copyrights,
trade secrets or other intangible assets or intellectual property rights in excess of $250,000, or
disclosed any proprietary confidential information to any person except to customers in the
ordinary course of business;

               (g) suffered any material losses or waived any rights of material value, whether or not in the
ordinary course of business, or suffered the loss of any material amount of prospective business;

               (h) made any changes in employee compensation except in the ordinary course of business and
consistent with past practices;

               (i) made capital expenditures or commitments therefor that aggregate in excess of $250,000;

               (j) entered into any material transaction, whether or not in the ordinary course of business
that has not been disclosed in the Commission Documents;

               (k) suffered any material damage, destruction or casualty loss, whether or not covered by
insurance;

               (l) experienced any material problems with labor or management in connection with the terms
and conditions of their employment;

               (m) altered its method of accounting, except to the extent required by GAAP;

               (n) issued any equity securities to any officer, director or affiliate (as such term is
defined in Rule 144 of the Securities Act), except pursuant to existing Company stock, option,
equity incentive or similar incentive plans; or

               (o) entered into an agreement, written or otherwise, to take any of the foregoing actions.

          u. Solvency. The Company has not taken, nor does it have any intention to take, any
steps to seek protection pursuant to any bankruptcy or similar law. The Company does not have any
actual knowledge nor has it received any written notice that its creditors intend to initiate
involuntary bankruptcy proceedings or any actual knowledge of any fact that, as of the date hereof,
would reasonably lead a creditor to do so. After giving effect to the transactions contemplated
hereby to occur at the Closing and in connection with the New Senior Credit Facility, the Company
will not be Insolvent (as hereinafter defined). For purposes of this Agreement, “Insolvent” means
(i) the Company is unable to pay its debts and liabilities, subordinated, contingent or otherwise,
as such debts and liabilities become absolute and matured, (ii) the Company intends to incur or
believes that it will incur debts that would be beyond its ability to pay as such debts mature or
(iii) the Company has unreasonably small capital with which to conduct the business in which it is
engaged as such business is now conducted and is proposed to be conducted.

          v. Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other
relationship between the Company and an unconsolidated or other off balance sheet entity that is
required to be disclosed by the Company in its Exchange Act filings and is not so disclosed or that
if made or not made would be reasonably likely to have a Material Adverse Effect.

          w. Transactions With Affiliates. Except as set forth in the Commission Documents, none
of the officers, directors or employees of the Company is presently a party to any transaction with
the Company or any Subsidiary (other than for ordinary course services as employees, officers or
directors), including any contract, agreement or other arrangement providing for the furnishing of
services to or by, providing for rental of real or personal property to or from, or otherwise
requiring payments to or from any such officer, director or employee or, to the knowledge of the
Company, any

40

 

corporation, partnership, trust or other entity in which any such officer, director, or employee
has a substantial interest or is an officer, director, trustee or partner.

          x. Insurance. The Company and each Subsidiary are insured by insurers of recognized
financial responsibility against such losses and risks and in such amounts as management of the
Company believes to be prudent and customary in the businesses in which the Company and each
Subsidiary are engaged. Neither the Company nor any Subsidiary has been refused any insurance
coverage sought or applied for and neither the Company nor any Subsidiary has any reason to believe
that it will not be able to renew its existing insurance coverage as and when such coverage expires
or to obtain similar coverage from similar insurers as may be necessary to continue its business at
a cost that would not have a Material Adverse Effect.

          y. Title. Except as set forth in the Commission Documents, the Company and each
Subsidiary have good and marketable title to all personal property owned by them which is material
to their respective business, in each case free and clear of all liens. Any real property and
facilities held under lease by the Company or any Subsidiary are held by them under valid,
subsisting and enforceable leases with such exceptions as are not material and do not interfere
with the use made and proposed to be made of such property and buildings by the Company or any
Subsidiary.

          z. Intellectual Property Rights. The Company and its Subsidiaries own or possess the
rights to use all patents, trademarks, domain names (whether or not registered) and any patentable
improvements or copyrightable derivative works thereof, websites and intellectual property rights
relating thereto, service marks, trade names, copyrights, licenses and authorizations which are
necessary for the conduct of its business as now conducted (collectively, the “Intellectual
Property Rights”) without any conflict with the rights of others, except any failures as,
individually or in the aggregate, are not reasonably likely to have a Material Adverse Effect.
Neither the Company nor any Subsidiary has received a written notice that the Intellectual Property
Rights used by the Company or any Subsidiary violates or infringes upon the rights of any Person.
To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is
no existing infringement by another Person of any of the Intellectual Property Rights. The Company
and its Subsidiaries have taken reasonable measures to protect the value of the Intellectual
Property Rights.

          aa. Environmental Laws. The Company and each of its Subsidiaries (a) are in compliance
with any and all Environmental Laws (as hereinafter defined), (b) have received all permits,
licenses or other approvals required of them under applicable Environmental Laws to conduct their
respective businesses and (c) are in compliance with all terms and conditions of any such permit,
license or approval where, in each of the foregoing clauses (a), (b) and (c), the failure to so
comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse
Effect. The term “Environmental Laws” means all federal, state, local or foreign laws relating to
pollution or protection of human health or the environment (including, without limitation, ambient
air, surface water, groundwater, land surface or subsurface strata), including, without limitation,
laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants,
contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into
the environment, or otherwise relating to the manufacture, processing, distribution, use,
treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all
authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses,
notices or notice letters, orders, permits, plans or regulations issued, entered, promulgated or
approved thereunder.

          bb. Material Contracts. Each contract of the Company that involves expenditures or
receipts in excess of $500,000 (each, a “Material Contract”) is in full force and effect and is
valid and enforceable in accordance with its terms. The Company is and has been in full compliance
with all applicable terms and requirements of each Material Contract and no event has occurred or
circumstance exists that (with or without notice or lapse of time) may contravene, conflict with or
result in a violation or breach of, or give the Company or any other entity the right to declare a
default or exercise any remedy under, or to accelerate the maturity or performance of, or to
cancel, terminate or modify any Material Contract. The Company has not given or received from any
other Person any notice or other communication (whether oral or written) regarding any actual,
alleged, possible or potential violation or breach of, or default under, any Material Contract.

          cc. Ranking of Series A Preferred Stock. No capital stock of the Company is senior to
or ranks pari passu with the Series A Preferred Stock in right of payment, whether with respect of
payment of redemptions, interest, damages or upon liquidation or dissolution or otherwise.

          dd. Manipulation of Price. The Company has not, and to its knowledge no one acting on
its behalf has, taken, directly or indirectly, any action designed to cause or to result or that
could reasonably be expected to cause or result, in the stabilization or manipulation of the price
of any security of the Company to facilitate the sale or resale of any of the Securities.

41

 

          ee. Listing and Maintenance Requirements. The Company has not, in the 12 months
preceding the date hereof, received notice from any trading market on which the Common Stock is or
has been listed or quoted to the effect that the Company is not in compliance with the listing or
maintenance requirements of such trading market. The Company is in compliance with all such
maintenance requirements.

          ff. Application of Takeover Protections. The Company and its Board of Directors have
taken all necessary action, if any, in order to render inapplicable any control share acquisition,
business combination, poison pill (including any distribution under a rights agreement) or other
similar anti-takeover provision under the Company’s Certificate of Incorporation (or similar
charter documents) or the laws of its state of incorporation that is or could become applicable to
Vicis as a result of Vicis and the Company fulfilling their obligations or exercising their rights
under the Transaction Documents, including without limitation the Company’s issuance of the
Securities and Vicis’s ownership of the Securities.

          gg. Disclosure. All written disclosure provided to Vicis regarding the Company, its
business and the transactions contemplated hereby, including the Schedules to this Agreement,
furnished by or on behalf of the Company are true and correct and do not contain any untrue
statement of a material fact or omit to state any material fact necessary in order to make the
statements made therein, in light of the circumstances under which they were made, not misleading.

     2. Representations and Warranties of Vicis. Vicis hereby represents and warrants to
the Company as follows as of the date hereof and as of the Closing Date:

          a. Organization and Standing of Vicis. Vicis is a trust duly organized, validly existing and
in good standing under the laws of the jurisdiction of its organization.

          b. Authorization and Power. Vicis has the requisite power and authority to enter into and
perform the Transaction Documents and to purchase or otherwise acquire the Securities being issued
to it hereunder. The execution, delivery and performance of the Transaction Documents by Vicis and
the consummation by it of the transactions contemplated hereby have been duly authorized by all
necessary corporate or partnership action, and no further consent or authorization of such Vicis,
as applicable, or its Board of Directors, stockholders, or partners, as the case may be, is
required. When executed and delivered by Vicis, the Transaction Documents shall constitute valid
and binding obligations of Vicis enforceable against such Vicis in accordance with their terms,
except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation, conservatorship, receivership or similar laws relating to, or affecting
generally the enforcement of, creditor’s rights and remedies or by other equitable principles of
general application.

          c. No Conflict. The execution, delivery and performance of the Transaction Documents by Vicis
and the consummation by Vicis of the transactions contemplated thereby and hereby do not and will
not (i) violate any provision of Vicis’s charter or organizational documents; (ii) conflict with,
or constitute a default (or an event which with notice or lapse of time or both would become a
default) under, or give to others any rights of termination, amendment, acceleration or
cancellation of, any agreement, mortgage, deed of trust, indenture, note, bond, license, lease
agreement, instrument or obligation to which Vicis is a party or by which Vicis’s respective
properties or assets are bound; or (iii) result in a violation of any federal, state, local or
foreign statute, rule, regulation, order, judgment or decree (including federal and state
securities laws and regulations) applicable to Vicis by which any property or asset of Vicis is
bound or affected, except, in all cases, other than violations pursuant to clauses (i) or (iii)
(with respect to federal and state securities laws) above, for such conflicts, defaults,
terminations, amendments, acceleration, cancellations and violations as would not, individually or
in the aggregate, materially and adversely affect Vicis’s ability to perform its obligations under
the Transaction Documents.

          d. Acquisition for Investment. Vicis is acquiring the Securities solely for its own account
and not with a view to or for sale in connection with distribution. Vicis does not have a present
intention to sell any of the Securities, or a present arrangement (whether or not legally binding)
or intention to effect any distribution of any of the Securities to or through any person or
entity; provided, however, that by making the representations herein, Vicis does not agree to hold
the Securities for any minimum or other specific term and reserves the right to dispose of the
Securities at any time in accordance with federal and state securities laws applicable to such
disposition. Vicis acknowledges that it (i) has such knowledge and experience in financial and
business matters such that Vicis is capable of evaluating the merits and risks of Vicis’s
investment in the Company; (ii) is able to bear the financial risks associated with an investment
in the Securities; and (iii) has been given full access to such records of the Company and the
Subsidiaries and to the officers of the Company and the Subsidiaries as it has deemed necessary or
appropriate to conduct its due diligence investigation.

42

 

          e. Rule 144. Vicis acknowledges that the Securities have not been registered under the
Securities Act of 1933, as amended (the “Act”), or any applicable state securities laws in reliance
upon exemption provisions of the Act and such other laws; and accordingly, no Federal or state
agency has made any recommendation or endorsement as to, or otherwise passed on the merits of,
purchasing the Securities. Vicis further acknowledges that there is no public market for the
Securities, other than a limited market for the Company’s shares of Common Stock, and that it will
not be possible to readily liquidate its investment. Vicis must bear the economic risks of
investment for an indefinite period of time and Vicis understands that the Securities must be held
indefinitely unless such Securities are registered under the Securities Act or an exemption from
registration is available. Vicis acknowledges that such person is familiar with Rule 144 of the
rules and regulations of the Commission, as amended, promulgated pursuant to the Securities Act
(“Rule 144”), and that such Vicis has been advised that Rule 144 permits resales only under certain
circumstances. Vicis understands that, to the extent that Rule 144 is not available, such Vicis
will be unable to sell any Securities without either registration under the Securities Act or the
existence of another exemption from such registration requirement.

          f. Independent Inquiry. Vicis has been given (i) access to all books and records, legal
documents and other material information of the Company; (ii) access to all material contracts and
documents of the Company relating to the Securities and the Company’s business; and (iii) an
opportunity to ask questions of and receive answers from the executive officers of the Company,
regarding the information in (i) and (ii) above. Vicis has made such investigation and examination
of the affairs of the Company and has obtained such information relating thereto as he or she deems
necessary to verify the accuracy of the information furnished to him or her. Vicis has received no
representation or warranty from any person regarding the Company or its business or prospects, or
the Securities; and Vicis acknowledges that the ability of the Company to achieve its business
objective is uncertain. Vicis understands that an investment in the Company is extremely risky and
acknowledges reviewing all of the Risk Factors contained in the Commission Documents.

          g. General. Vicis understands that the Securities are being offered and sold in reliance on a
transactional exemption from the registration requirements of federal and state securities laws and
the Company is relying upon the truth and accuracy of the representations, warranties, agreements,
acknowledgments and understandings of such Vicis set forth herein in order to determine the
applicability of such exemptions and the suitability of such Vicis to acquire the Securities. The
information provided to the Company by Vicis is true and accurate and contains no material
misstatements. Vicis understands that no United States federal or state agency or any government or
governmental agency has passed upon or made any recommendation or endorsement of the Securities.
Commencing on the date that Vicis was initially contacted regarding an investment in the
Securities, its has not engaged in any short sale of any of the Securities and will not engage in
any such short sale prior to the consummation of the transactions contemplated by this Agreement.

          h. No General Solicitation. Vicis acknowledges that the Securities were not offered to such
Vicis, as applicable, by means of any form of general or public solicitation or general
advertising, or publicly disseminated advertisements or sales literature, including (i) any
advertisement, article, notice or other communication published in any newspaper, magazine, or
similar media, or broadcast over television or radio; or (ii) any seminar or meeting to which such
Vicis, as applicable, was invited by any of the foregoing means of communications. Vicis in making
the decision to purchase the Securities, has relied upon independent investigation made by it and
has not relied on any information or representations made by third parties.

          i. Accredited Vicis. Vicis is an “accredited investor” (as defined in Rule 501 of Regulation
D), and such Vicis has such experience in business and financial matters that it is capable of
evaluating the merits and risks of an investment in the Securities. Such Vicis is not required to
be registered as a broker-dealer under Section 15 of the Exchange Act and such Vicis is not a
broker-dealer. Vicis acknowledges that an investment in the Securities is speculative and involves
a high degree of risk.

          j. Sophistication. Vicis has sufficient knowledge and experience in business and financial
matters to evaluate the merits and risks of an investment in the Company and is able to bear the
economic risks inherent in this investment and has the ability, at the present time, to afford a
complete loss of the undersigned’s entire investment in the Company. Vicis’s overall commitment to
investments which are not readily marketable is not disproportionate to his or her net worth in
light of his or her business or investments, and Vicis’s investment in the Company will not cause
such overall commitment to be disproportionate. Vicis has adequate means of providing for his or
her current financial needs and possible personal contingencies and has no need for liquidity in
this investment.

          k. Regulation M. Vicis has complied and will comply with Regulation M promulgated under the
Exchange Act with respect to the transactions contemplated by this Agreement.

43

 

ARTICLE III

COVENANTS

     The Company covenants with Vicis as to each provision in this Article III as follows,
which covenants are for the benefit of Vicis and its permitted assignees.

     1. Securities Compliance. The Company shall notify the Commission in accordance with
its rules and regulations of the transactions contemplated by any of the Transaction Documents and
shall take all other necessary action and proceedings as may be required and permitted by
applicable law, rule and regulation, for the legal and valid issuance of the Securities to Vicis or
their respective subsequent holders.

     2. Listing; Filings. The Company will take all action necessary to continue the
trading of its Common Stock on the OTC Bulletin Board and if and when issued to list the Conversion
Shares. The Company further agrees, if the Company applies to have the Common Stock traded on any
other trading market, it will include in such application all of the Conversion Shares, and will
take such other action as is necessary to cause all of the Conversion Shares to be listed on such
other trading market as promptly as possible. The Company will take all action reasonably necessary
to continue the listing and trading of its Common Stock on, and will comply in all respects with
the Company’s reporting, filing and other obligations under the bylaws or rules of, each such
Trading Market on which the Company’s Common Stock is listed or trades. Subject to the terms of the
Transaction Documents, the Company further covenants that it will take such further action as Vicis
may reasonably request, all to the extent required from time to time to enable Vicis to sell its
shares of Common Stock without registration under the Securities Act within and subject to the
limitations provided by Rule 144 promulgated under the Securities Act.

     3. Inspection Rights. Provided same would not be in violation of Regulation FD, the
Company shall permit, during normal business hours and upon reasonable request and reasonable
notice, Vicis, or any employees, agents or representatives thereof, for purposes reasonably related
to such Vicis’s interests as a stockholder, to examine the publicly available, non-confidential
records and books of account of, and visit and inspect the properties, assets, operations and
business of the Company and any subsidiary, and to discuss the publicly available, non-confidential
affairs, finances and accounts of the Company and any subsidiary with any of its officers,
consultants, directors, and key employees.

     4. Compliance with Laws. The Company shall comply, and cause each subsidiary to
comply, with all applicable laws, rules, regulations and orders, noncompliance with which would be
reasonably likely to have a Material Adverse Effect.

     5. Keeping of Records and Books of Account. The Company shall keep and cause each
subsidiary to keep adequate records and books of account, in which complete entries will be made in
accordance with GAAP consistently applied, reflecting all financial transactions of the Company and
its subsidiaries, and in which, for each fiscal year, all proper reserves for depreciation,
depletion, obsolescence, amortization, taxes, bad debts and other purposes in connection with its
business shall be made.

     6. Other Agreements. The Company shall not enter into any agreement which, by its
terms, would restrict or impair the Company’s or any subsidiary’s right or ability to perform under
this Article III.

     7. Use of Proceeds. The net proceeds from the sale of the Securities hereunder shall
be used by the Company in accordance with the Additional Equity Letter dated as of the date hereof
from the Company to CHATHAM CREDIT MANAGEMENT III, LLC, with the “Cash to Balance Sheet” (as
referenced in that letter) being used, in the sole discretion of the Company, including for
acquisitions and for working capital and general corporate purposes, including, but not limited to,
growth and capital initiatives, investor and public relations, consulting fees, and transaction
related fees.

     8. Reporting Status. For a period of not less than two (2) years after the Closing,
(a) the Company shall timely file all reports required to be filed with the Commission pursuant to
the Exchange Act, and the Company shall not terminate its status as an issuer required to file
reports under the Exchange Act even if the Exchange Act or the rules and regulations thereunder
would permit such termination, and (b) the Company shall retain an investor relations firm,
selected by the Company, which systematically prepares and distributes information to potential
investors about developments in the Company’s business as part of an active investor relations
program.

44

 

     9. Transfer Taxes. All applicable sales taxes, documentary transfer taxes, recording
and filing fees, and other costs (but not including, without limitation, any attorney’s fees
incurred by the Company or income, capital gains, intangible or similar taxes) that may be due or
payable as a result of the conveyance or deliver of the Securities to be conveyed and transferred
or other transactions contemplated hereby, whether levied on the Company or Vicis shall be paid by
the Company.

     10. Authorization of and Reservation of Additional Shares of Common Stock. On or prior
to Closing, the Company shall take all action necessary to reserve sufficient shares for the full
issuance of the Conversion Shares and thereafter the Company will at all times cause there to be
reserved for issuance a sufficient number of shares of Common Stock for the issuance of the
Conversion Shares.

     11. Maintenance of Corporate Existence. The Company shall and shall cause its
subsidiaries to, maintain in full force and effect its corporate existence, rights and franchises
and all material terms of licenses and other rights to use licenses, trademarks, trade names,
service marks, copyrights, patents or processes owned or possessed by it and necessary to the
conduct of its business, except where the failure to maintain such corporate existence, rights,
franchises, licenses and rights to use licenses, trademarks, trade names, service marks,
copyrights, patents or processes would not (a) result in a Material Adverse Effect or (b)
materially adversely affect the rights of Vicis under any Transaction Document.

     12. Maintenance of Properties. The Company shall and shall cause its subsidiaries to,
keep each of its properties necessary to the conduct of its business in good repair, working order
and condition, reasonable wear and tear excepted, and from time to time make all needful and proper
repairs, renewals, replacements, additions and improvements thereto; and the Company shall and
shall its subsidiaries to at all times comply with each material provision of all material leases
to which it is a party or under which it occupies property.

     13. Payment of Taxes. The Company shall and shall cause its subsidiaries to, promptly
pay and discharge, or cause to be paid and discharged when due and payable, all lawful taxes,
assessments and governmental charges or levies imposed upon the income, profits, assets, property
or business of the Company and its subsidiaries; provided, however, that any such tax, assessment,
charge or levy need not be paid if the validity thereof shall be contested timely and in good faith
by appropriate proceedings, if the Company or its subsidiaries shall have set aside on its books
adequate reserves with respect thereto, and the failure to pay shall not be prejudicial in any
material respect to the holders of the Securities, and provided, further, that the Company or its
subsidiaries will pay or cause to be paid any such tax, assessment, charge or levy forthwith upon
the commencement of proceedings to foreclose any Lien which may have attached as security therefor.

     14. Payment of Indebtedness. The Company shall, and shall cause its subsidiaries to,
pay or cause to be paid when due all Indebtedness incident to the operations of the Company or its
subsidiaries (including, without limitation, claims or demands of workmen, material-men, vendors,
suppliers, mechanics, carriers, warehousemen and landlords) which, if unpaid might become a Lien
(except for Permitted Liens) upon the assets or property of the Company or its subsidiaries, except
where the Company (or its subsidiary, as the case may be) disputes the payment of such Indebtedness
in good faith by appropriate proceedings

     15. Maintenance of Insurance. The Company shall and shall cause its subsidiaries to,
keep its assets which are of an insurable character insured by financially sound and reputable
insurers against loss or damage by theft, fire, explosion and other risks customarily insured
against by companies in the line of business of the Company or its subsidiaries, in amounts
sufficient to prevent the Company and its subsidiaries from becoming a co-insurer of the property
insured; and the Company shall and shall cause its subsidiaries to maintain, with financially sound
and reputable insurers, insurance against other hazards and risks and liability to persons and
property to the extent and in the manner customary for companies in similar businesses similarly
situated or as may be required by law, including, without limitation, general liability, fire and
business interruption insurance, and product liability insurance as may be required pursuant to any
license agreement to which the Company or its subsidiaries is a party or by which it is bound.

     16. Payment of the Preferred Share Dividends. The Company shall pay the dividends on,
and redeem, the Acquired Shares, in the time, the manner and the form as provided in the
Certificate of Designation for the Series A Preferred Stock.

     17. Further Assurances. From time to time the Company shall execute and deliver to
Vicis and Vicis shall execute and deliver to the Company such other instruments, certificates,
agreements and documents and take such other action and do all other things as may be reasonably
requested by the other party in order to implement or effectuate the terms and provisions of this
Agreement and any of the Securities.

45

 

     For purposes of Articles IV and V the term “subsidiary” shall be deemed to include each
Subsidiary and any subsidiary of the Company acquired or formed after the date hereof.

ARTICLE V

NEGATIVE COVENANTS

     The Company hereby covenants and agrees, so long as more than 25% of the aggregate amount of
authorized shares of Series A Preferred Stock remain outstanding (or such amount as adjusted for
stock splits, recapitalizations and similar transactions), it will not (and not allow any
subsidiary to), without the prior written consent of the holder(s) of more than 50% of number of
shares of Series A Preferred Stock outstanding (the “Majority Holders”), directly or indirectly:

     1. Distributions and Redemptions. (a) Except with respect to the Series A Preferred
Stock, declare or pay any dividends or make any distributions to any holder(s) of any shares of
capital stock of the Company or (a) purchase, redeem or otherwise acquire for value, directly or
indirectly, any shares of Common Stock of the Company or warrants or rights to acquire such Common
Stock, except as may be required by the terms of the Series A Preferred Stock; or (iii) purchase,
redeem or otherwise acquire for value, directly or indirectly, any shares of preferred stock of the
Company or warrants or rights to acquire such stock, except as may be required by the terms of such
preferred stock.

     2. Reclassification. Effect any reclassification, combination or reverse stock split
of the Common Stock.

     3. Indebtedness. Create, incur, assume, suffer, permit to exist, or guarantee,
directly or indirectly, any Indebtedness, excluding, however, from the operation of this covenant:

          Indebtedness to the extent disclosed in the Commission Documents filed prior to the date
hereof and otherwise existing on the date hereof;

          Indebtedness which may, from time to time be incurred or guaranteed by the Company which in
the aggregate principal amount does not exceed $250,000 and is subordinate to the Indebtedness
under this Agreement;

          the endorsement of instruments for the purpose of deposit or collection in the ordinary course
of business;

          Indebtedness relating to contingent obligations of the Company and its subsidiaries under
guaranties in the ordinary course of business of the obligations of suppliers, customers, and
licensees of the Company and its subsidiaries;

          Indebtedness relating to loans from the Company to its subsidiaries;

          Indebtedness relating to capital leases in an amount not to exceed $250,000; or

          accounts or notes payable arising out of the purchase of merchandise, supplies, equipment,
software, computer programs or services in the ordinary course of business.

     4. Capital Stock. Except for issuances to Vicis, issue any equity security that is
senior to or ranks pari passu with the Series A Preferred Stock, whether with respect to right of
payment of redemptions, interest, damages or upon liquidation or dissolution or otherwise.

     5. Liquidation or Sale. Sell, transfer, lease or otherwise dispose of 10% or more of
its consolidated assets (as shown on the most recent financial statements of the Company or the
subsidiary, as the case may be) in any single transaction or series of related transactions (other
than the sale of inventory in the ordinary course of business), or liquidate, dissolve,
recapitalize or reorganize in any form of transaction.

     6. Change of Control Transaction. Enter into a Change in Control Transaction. For
purposes of this Agreement, “Change in Control Transaction” means the occurrence of (a) an
acquisition by an individual or legal entity or “group” (as described in Rule 13d-5(b)(1)
promulgated under the Exchange Act) of effective control (whether through legal or beneficial
ownership of capital stock of the Company, by contract or otherwise) of in excess of fifty percent
(50%) of the voting securities of the Company (except that the acquisition of Securities by Vicis
shall not constitute a Change in Control for purposes of this Section), (b) a replacement at one
time or over time of more than one-half of the members of

46

 

the Board of the Company which is not approved by a majority of those individuals who are members
of the Board on the date hereof (or by those individuals who are serving as members of the Board on
any date whose nomination to the Board was approved by a majority of the members of the Board who
are members on the date hereof), (c) the merger or consolidation of the Company or any subsidiary
of the Company in one or a series of related transactions with or into another entity (except in
connection with a merger involving the Company solely for the purpose, and with the sole effect, of
reorganizing the Company under the laws of another jurisdiction; provided that the certificate of
incorporation and bylaws (or similar charter or organizational documents) of the surviving entity
are substantively identical to those of the Company and do not otherwise adversely impair the
rights of Vicis), or (d) the execution by the Company of an agreement to which the Company is a
party or by which it is bound, providing for any of the events set forth above in (a), (b) or (c).

     7. Amendment of Charter Documents. Amend or waive any provision of the Certificate of
Incorporation or Bylaws of the Company in any way that materially adversely affects the rights of
Vicis without the prior written consent of Vicis.

     8. Senior Loan Amendment. The Company shall not further amend its senior credit
facility, after giving effect to the Senior Loan Amendment attached hereto as Exhibit A, if
such amendment would materially adversely affect the rights of Vicis under this Agreement.

ARTICLE VI

CERTIFICATE LEGEND

     1. Legend. Each certificate representing the Securities shall be stamped or otherwise
imprinted with a legend substantially in the following form (in addition to any legend required by
applicable state securities or “blue sky” laws):

THE SECURITIES REPRESENTED BY THIS CERTIFICATE (THE “SECURITIES”) HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR
ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF
UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES
LAWS OR THE COMPANY SHALL HAVE RECEIVED AN OPINION OF COUNSEL THAT REGISTRATION OF
SUCH SECURITIES UNDER THE SECURITIES ACT AND UNDER THE PROVISIONS OF APPLICABLE
STATE SECURITIES LAWS IS NOT REQUIRED.

     Prior to registration of the Conversion Shares under the Securities Act, all such certificates
shall bear the restrictive legend specified in this Section. Certificates evidencing the Conversion
Shares shall not contain any legend (including the legend set forth in this Section), (i) while a
registration statement (including the Registration Statement) covering the resale of such security
is effective under the Securities Act, or (ii) following any sale of such Conversion Shares
pursuant to Rule 144, or (iii) if such Conversion Shares are eligible for sale under Rule 144 by
Vicis without limitation as to volume or manner of sale, or (iv) if such legend is not required
under applicable requirements of the Securities Act (including judicial interpretations and
pronouncements issued by the Staff of the Commission). The Company shall cause its counsel to issue
a legal opinion to the Company’s transfer agent promptly after the effective date of a registration
statement covering such Conversions Shares, if required by the Company’s transfer agent, to effect
the removal of the legend hereunder. If all or any portion of the Acquired Shares is converted at a
time when there is an effective registration statement to cover the resale of the Conversion
Shares, such Conversion Shares, as the case may be, shall be issued free of all legends. The
Company agrees that following the effective date of the registration statement covering Conversion
Shares or at such time as such legend is no longer required under this Section, it will, no later
than five (5) trading days following the delivery by Vicis to the Company or the Company’s transfer
agent of a certificate representing Conversion Shares, as the case may be, issued with a
restrictive legend (such date, the “Delivery Date”), deliver or cause to be delivered to Vicis a
certificate representing such Securities that is free from all restrictive and other legends. The
Company may not make any notation on its records or give instructions to any transfer agent of the
Company that enlarge the restrictions on transfer set forth in this Section. Whenever a certificate
representing the Conversion Shares is required to be issued to Vicis without a legend, in lieu of
delivering physical certificates representing the Conversion Shares, provided the Company’s
transfer agent is participating in the Depository Trust Company (“DTC”) Fast Automated

47

 

Securities Transfer program, the Company shall use its reasonable best efforts to cause its
transfer agent to electronically transmit the Conversion Shares to Vicis by crediting the account
of such Vicis’s Prime Broker with DTC through its Deposit Withdrawal Agent Commission (“DWAC”)
system (to the extent not inconsistent with any provisions of this Agreement).

     2. Liquidated Damages. The Company understands that a delay in the delivery of
unlegended certificates for the Conversion Shares as set forth in Section 1 hereof beyond the
Delivery Date could result in economic loss to Vicis. If the Company fails to deliver to a Vicis
such shares via DWAC or a certificate or certificates pursuant to this Section hereunder by the
Delivery Date, the Company shall pay to Vicis, in cash, as partial liquidated damages and not as a
penalty, for each $500 of Conversion Shares (based on the closing price of the Common Stock
reported by the principal trading market on the date such Securities are submitted to the Company’s
transfer agent) subject to Section 1, $10 per trading day (increasing to $15 per trading day five
(5) trading days after such damages have begun to accrue and increasing to $20 per trading day ten
(10) trading days after such damages have begun to accrue) for each trading day after the Legend
Removal Date until such certificate is delivered. Nothing herein shall limit Vicis’s right to
pursue actual damages for the Company’s failure to deliver certificates representing any Securities
as required by the Transaction Documents, and Vicis shall have the right to pursue all remedies
available to it at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief.

     3. Sales by Vicis. Vicis agrees that the removal of the restrictive legend from
certificates representing Securities as set forth in Section 1 is predicated upon the Company’s
reliance that Vicis will sell any Securities pursuant to either the registration requirements of
the Securities Act, including any applicable prospectus delivery requirements, or an exemption
therefrom.

ARTICLE VII

INDEMNIFICATION

     1. General Indemnity. The Company agrees to indemnify, defend and hold harmless Vicis
(and their respective directors, officers, affiliates, agents, successors and assigns) from and
against any and all losses, liabilities, deficiencies, costs, damages and expenses (including,
without limitation, reasonable attorneys’ fees, charges and disbursements) incurred by Vicis as a
result of any inaccuracy in or breach of the representations, warranties or covenants made by the
Company herein. Vicis agrees to indemnify and hold harmless the Company and its directors,
officers, affiliates, agents, successors and assigns from and against any and all losses,
liabilities, deficiencies, costs, damages and expenses (including, without limitation, reasonable
attorneys’ fees, charges and disbursements) incurred by the Company as result of any inaccuracy in
or breach of the representations, warranties or covenants made by such Vicis herein.

     2. Indemnification Procedure. Any party entitled to indemnification under this
Article VII (an “indemnified party”) will give written notice to the indemnifying party of
any matter giving rise to a claim for indemnification; provided, that the failure of any party
entitled to indemnification hereunder to give notice as provided herein shall not relieve the
indemnifying party of its obligations under this Article VII except to the extent that the
indemnifying party is actually prejudiced by such failure to give notice. In case any such action,
proceeding or claim is brought against an indemnified party in respect of which indemnification is
sought hereunder, the indemnifying party shall be entitled to participate in and, unless in the
reasonable judgment of the indemnifying party a conflict of interest between it and the indemnified
party exists with respect to such action, proceeding or claim (in which case the indemnifying party
shall be responsible for the reasonable fees and expenses of one separate counsel for the
indemnified parties), to assume the defense thereof with counsel reasonably satisfactory to the
indemnified party. In the event that the indemnifying party advises an indemnified party that it
will contest such a claim for indemnification hereunder, or fails, within thirty (30) days of
receipt of any indemnification notice to notify, in writing, such person of its election to defend,
settle or compromise, at its sole cost and expense, any action, proceeding or claim (or
discontinues its defense at any time after it commences such defense), then the indemnified party
may, at its option, defend, settle or otherwise compromise or pay such action or claim. In any
event, unless and until the indemnifying party elects in writing to assume and does so assume the
defense of any such claim, proceeding or action, the indemnified party’s costs and expenses arising
out of the defense, settlement or compromise of any such action, claim or proceeding shall be
losses subject to indemnification hereunder. The indemnified party shall cooperate fully with the
indemnifying party in connection with any negotiation or defense of any such action or claim by the
indemnifying party and shall furnish to the indemnifying party all information reasonably available
to the indemnified party which relates to such action or claim. The indemnifying party shall keep
the indemnified party fully apprised at all times as to the status of the defense or any settlement
negotiations with respect thereto. If the indemnifying party elects to defend any such action or
claim, then the indemnified party shall be entitled to participate in such defense

48

 

with counsel of its choice at its sole cost and expense. The indemnifying party shall not be
liable for any settlement of any action, claim or proceeding effected without its prior written
consent. Notwithstanding anything in this Article VII to the contrary, the indemnifying
party shall not, without the indemnified party’s prior written consent, settle or compromise any
claim or consent to entry of any judgment in respect thereof which imposes any future obligation on
the indemnified party or which does not include, as an unconditional term thereof, the giving by
the claimant or the plaintiff to the indemnified party of a release from all liability in respect
of such claim. The indemnification obligations to defend the indemnified party required by this
Article VI shall be made by periodic payments of the amount thereof during the course of
investigation or defense, as and when bills are received or expense, loss, damage or liability is
incurred, so long as the indemnified party shall refund such moneys if it is ultimately determined
by a court of competent jurisdiction that such party was not entitled to indemnification. The
indemnity agreements contained herein shall be in addition to (a) any cause of action or similar
rights of the indemnified party against the indemnifying party or others, and (b) any liabilities
the indemnifying party may be subject to pursuant to the law. No indemnifying party will be liable
to the indemnified party under this Agreement to the extent, but only to the extent that a loss,
claim, damage or liability is attributable to the indemnified party’s breach of any of the
representations, warranties or covenants made by such party in this Agreement or in the other
Transaction Documents.

ARTICLE VIII

MISCELLANEOUS

     1. TO RESIDENTS OF FLORIDA: THE INTEREST OFFERED HEREIN HAVE NOT BEEN REGISTERED WITH
THE FLORIDA DIVISION OF SECURITIES. PURSUANT TO FLORIDA STATUTES, SECTION 517.061(11) (A) (5),
INVESTORS MAY ELECT, WITHIN THREE (3) BUSINESS DAYS AFTER DELIVERY OF THEIR SUBSCRIPTION AGREEMENT
AND THE PURCHASE PRICE FOR THE INTEREST, TO WITHDRAW THEIR SUBSCRIPTION AND RECEIVE A FULL REFUND
(WITHOUT INTEREST) OF SUCH PURCHASE PRICE. THIS WITHDRAWAL WILL BE WITHOUT ANY FURTHER LIABILITY TO
ANY PERSON. TO ACCOMPLISH SUCH WITHDRAWAL, AN INVESTOR SHOULD SEND A LETTER INDICATING THE
INTENTION TO WITHDRAW, POSTMARKED PRIOR TO THE END OF THE THIRD BUSINESS DAY AFTER DELIVERY OF
FUNDS TO THE PARTNERSHIP, RETURN RECEIPT REQUESTED, TO THE COMPANY AT THE ADDRESS SET FORTH HEREIN.
ANY ORAL REQUESTS FOR RESCISSION SHOULD BE ACCOMPANIED BY A REQUEST FOR WRITTEN CONFIRMATION THAT
THE ORAL REQUEST WAS RECEIVED ON A TIMELY BASIS.

     2. Fees and Expenses. Each party shall pay the fees and expenses of its advisors,
counsel, accountants and other experts, if any, and all other expenses, incurred by such party
incident to the negotiation, preparation, execution, delivery and performance of this Agreement.

     3. Governing Law; Consent to Jurisdiction; Venue. This Agreement shall be governed by
and construed in accordance with the internal laws of the State of Florida, without giving effect
to any of the conflicts of law principles which would result in the application of the substantive
law of another jurisdiction. This Agreement shall not be interpreted or construed with any
presumption against the party causing this Agreement to be drafted. The parties agree that venue
for any dispute arising under this Agreement will lie exclusively in the state or federal courts
located in Hillsborough County, Florida, and the parties irrevocably waive any right to raise forum
non conveniens or any other argument that Florida is not the proper venue. The parties irrevocably
consent to personal jurisdiction in the state and federal courts of the state of Florida. Each
party hereto consent to process being served in any such suit, action or proceeding by mailing a
copy thereof to such party at the address in effect for notices to it under this Agreement and
agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing in this section shall affect or limit any right to serve process in any other
manner permitted by law. The parties hereto hereby agree that the prevailing party in any suit,
action or proceeding arising out of or relating to the Securities, this Agreement or the other
Transaction Documents, shall be entitled to reimbursement for reasonable legal fees from the
non-prevailing party. The parties hereby waive all rights to a trial by jury.

     4. Entire Agreement; Amendment. This Agreement and the Transaction Documents contain
the entire understanding and agreement of the parties with respect to the matters covered hereby
and they supersede all prior understandings and agreements with respect to said subject matter, all
of which are merged herein. No provision of this Agreement may be waived or amended other than by a
written instrument signed by the Company and Vicis.

     5. Notices. All notices and other communications given or made pursuant to this
Agreement shall be in writing and shall be deemed effectively given: (a) upon personal delivery to
the party to be notified; (b) when sent by

49

 

confirmed electronic mail or facsimile if sent during normal business hours of the recipient,
and if not so confirmed, then on the next business day; (c) five (5) days after having been sent by
registered or certified mail, return receipt requested, postage prepaid; or (d) one (1) business
day after deposit with a nationally recognized overnight courier, specifying next day delivery,
with written verification of receipt. All communications shall be sent to the respective parties at
their address as set forth below or to such address or facsimile number as subsequently modified by
written notice given in accordance with this section.

     All notices to the Company shall be sent to:

Brookside Technology Holdings Corp.

15500 Roosevelt Blvd., Ste. 101

Clearwater, FL 33760

Attn: Michael Nole, Chief Executive Officer

Facsimile: (813) 854-1045

     If to Vicis:

126 East 56th Street

Tower 56, Suite 700

New York, NY 10022

Any party hereto may from time to time change its address for notices by giving written notice of
such changed address to the other parties hereto.

     6. Waivers. No waiver by any party of any default with respect to any provision,
condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future
or a waiver of any other provision, condition or requirement hereof, nor shall any delay or
omission of any party to exercise any right hereunder in any manner impair the exercise of any such
right accruing to it thereafter.

     7. Headings. The article, section and subsection headings in this Agreement are for
convenience only and shall not constitute a part of this Agreement for any other purpose and shall
not be deemed to limit or affect any of the provisions hereof.

     8. Successors and Assigns. This Agreement shall be binding upon and inure to the
benefit of the parties and their successors and assigns. After the Closing, the assignment by a
party to this Agreement of any rights hereunder shall not affect the obligations of such party
under this Agreement.

     9. No Third Party Beneficiaries. This Agreement is intended for the benefit of the
parties hereto and their respective permitted successors and assigns and is not for the benefit of,
nor may any provision hereof be enforced by, any other person.

     10. Survival. The representations and warranties shall survive the execution and
delivery hereof and the Closing.

     11. Counterparts. This Agreement may be executed in any number of counterparts, all of
which taken together shall constitute one and the same instrument and shall become effective when
counterparts have been signed by each party and delivered to the other parties hereto, it being
understood that all parties need not sign the same counterpart.

     12. Severability. The provisions of this Agreement are severable and, in the event
that any court of competent jurisdiction shall determine that any one or more of the provisions or
part of the provisions contained in this Agreement shall, for any reason, be held to be invalid,
illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not
affect any other provision or part of a provision of this Agreement and this Agreement shall be
reformed and construed as if such invalid or illegal or unenforceable provision, or part of such
provision, had never been contained herein, so that such provisions would be valid, legal and
enforceable to the maximum extent possible.

     13. Recitals. The parties hereto agree the Recitals set forth above are true and
accurate.

[Remainder of this page intentionally left blank; Signature page follows]

50

 

[Signature page to Securities Purchase and Loan Conversion Agreement]

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above
stated.

	 	 	 	 	 
	Brookside Technology Holdings Corp.

 	 	 
	By:  	 	 	 
	 	Michael Nole, Chief Executive Officer 	 	 
	 	 	 	 
	 
	PURCHASER OF SERIES A PREFERRED STOCK

Vicis Capital Master Fund

 	 	 
	By:  	Vicis Capital LLC
 	 	 
	 	 	 
	By:  	 	 	 
	 	Shad Stastney, Member and Chief Operating Officer 	 	 
	 	 	 	 
	 

51exv10w5

Exhibit 10.5

THIS WARRANT OR THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR
DISPOSITION MAY BE EFFECTED WITHOUT (i) AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO, (ii)
AN OPINION OF COUNSEL FOR THE HOLDER, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH
REGISTRATION IS NOT REQUIRED, (iii) RECEIPT OF A NO-ACTION LETTER(S) FROM THE APPROPRIATE
GOVERNMENTAL AUTHORITY(IES), OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF OF THIS WARRANT.

SERIES G WARRANT TO PURCHASE SHARES

OF COMMON STOCK

Brookside Technology Holdings Corp., a Florida corporation (the “COMPANY”), hereby certifies that,
for value received, Vicis Capital Master Fund, a sub-trust of Vicis Capital Series Master Trust, a
unit trust organized and existing under the laws of the Cayman Islands (the “HOLDER”) is the
registered Holder of a warrant (the “WARRANT”) to subscribe for and purchase 473,708,300 shares of
the fully paid and nonassessable Common Stock (as adjusted pursuant to Section 4 hereof,
the “WARRANT SHARES”) of the Company, at a price per share equal to $0.01 (the “WARRANT PRICE,” as
adjusted pursuant to Section 4 hereof), subject to the provisions and upon the terms and
conditions hereinafter set forth. This Warrant is the Warrant to purchase Common Stock issued
pursuant to that certain Securities Purchase and Loan Conversion Agreement, dated as of even date
herewith, between the Company and the Holder referred to therein (the “PURCHASE AGREEMENT”).
Capitalized terms used but not defined herein shall have the meanings ascribed to them in the
Purchase Agreement.

As used herein, (a) the term “COMMON STOCK” shall mean the Company’s presently authorized Common
Stock, par value $.001 per share, and any stock into or for which such Common Stock may hereafter
be converted or exchanged and (b) the term “DATE OF GRANT” shall mean April 12, 2010.

	1.	 	Term. The purchase right represented by this Warrant is exercisable, in whole or in
part, at any time after the Date of Grant (the “INITIAL EXERCISE DATE”) and from time to time
thereafter through and including the close of business on the date five (5) years from the
Initial Exercise Date (the “EXPIRATION DATE”).
	 
	2.	 	Exercise; Expiration; Redemption.

	 	a.	 	Method of Exercise; Payment; Issuance of New Warrant. Subject to Section
1 hereof, the purchase right represented by this Warrant may be exercised by the
Holder hereof, in whole or in part and from time to time after the Initial Exercise
Date, by the surrender of this Warrant (with the notice of exercise form attached
hereto as Exhibit A duly executed) at the principal office of the Company and
by the payment to the Company of an amount equal to the then applicable Warrant Price
multiplied by the number of Warrant Shares then being purchased. The person or persons
in whose name(s) any certificate(s) representing shares of Common Stock shall be
issuable upon exercise of this Warrant shall be deemed to have become the Holder(s) of
record of, and shall be treated for all purposes as the record Holder(s) of, the shares
represented thereby (and such shares shall be deemed to have been issued) immediately
prior to the close of business on the date or dates upon which this Warrant is
exercised. In the event of any exercise of the rights represented by this Warrant,
certificates for the shares of stock so purchased shall be delivered to the Holder
hereof as soon as possible and in any event within five (5) trading (the “SHARE
DELIVERY DATE”) days after such exercise and, unless this Warrant has been fully
exercised, a new Warrant representing the portion of the Warrant Shares, if any, with
respect to which this Warrant shall not then have been exercised shall also be issued
to the Holder hereof as soon as possible and in any event within such five (5) trading
day-period.
	 
	 	b.	 	Expiration. In the event that any portion of this Warrant is unexercised as of
the Expiration Date, such portion of this Warrant shall automatically expire, and the
Holder shall have no rights with respect to such unexercised portion of this Warrant.
	 
	 	c.	 	Maximum.

52

 

     (i) Notwithstanding anything to the contrary set forth in this Warrant, at no
time may a Holder of this Warrant exercise this Warrant to the extent that after
giving effect to such exercise, the Holder (together with the Holder’s affiliates)
would beneficially own (as determined in accordance with Section 13(d) of the
Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of
4.99% of the number of shares of Common Stock outstanding immediately after giving
effect to such exercise; provided, however, that upon a Holder of this Warrant
providing the Company with sixty-one (61) days notice (the “Waiver Notice”) that such
Holder would like to waive this Section with regard to any or all shares of Common
Stock issuable upon exercise of this Warrant, this Section will be of no force or
effect with regard to all or a portion of the Warrant referenced in the Waiver
Notice.

     (ii) Notwithstanding anything to the contrary set forth in this Warrant, at no
time may a Holder of this Warrant exercise this Warrant to the extent that after
giving effect to such exercise, the Holder (together with the Holder’s affiliates)
would beneficially own (as determined in accordance with Section 13(d) of the
Securities Exchange Act of 1934, as amended, and the rules thereunder) in excess of
9.99% of the number of shares of Common Stock outstanding immediately after giving
effect to such exercise; provided, however, that upon a Holder of this Warrant
providing the Company with a Waiver Notice that such Holder would like to waive this
Section with regard to any or all shares of Common Stock issuable upon exercise of
the Warrant, this Section shall be of no force or effect with regard to all or a
portion of the Warrant referenced in the Waiver Notice.

	 	d.	 	Company’s Failure to Timely Deliver Securities.

     (i) The Company understands that a delay in the delivery of the shares of Common
Stock upon exercise of this Warrant beyond the Share Delivery Date could result in
economic loss to the Holder. If the Company fails to deliver to the
Holder such shares via DWAC or a certificate or certificates pursuant to this Section by the
Share Delivery Date, the Company shall pay to the Holder, in cash, as partial
liquidated damages and not as a penalty, for each $500 of Warrant Shares (based on
the closing price of the Common Stock reported by the principal Trading Market on the
date such securities are submitted to the Company’s transfer agent), $10 per trading
day (increasing to $15 per trading day five (5) trading days after such damages have
begun to accrue and increasing to $20 per trading day ten (10) trading days after
such damages have begun to accrue) for each trading day after the Share Delivery Date
until such Common Stock certificate is delivered. Nothing herein shall limit a
Holder’s right to pursue actual damages for the Company’s failure to deliver
certificates, and the Holder shall have the right to pursue all remedies available to
it at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief. Notwithstanding anything to the contrary
contained herein, the Holder shall be entitled to withdraw an Exercise Notice, and
upon such withdrawal the Company shall only be obligated to pay the liquidated
damages accrued in accordance with this Section through the date the Exercise Notice
is withdrawn. Notwithstanding the foregoing, the Holder shall not be entitled to the
damages set forth herein for the delay in the delivery of the shares of Common Stock
upon exercise of this Warrant, if such delay is due to causes which are beyond the
reasonable control of the Company, including, but not limited to, acts of God, acts
of civil or military authority, fire, flood, earthquake, hurricane, riot, war,
terrorism, sabotage and/or governmental action, provided that the Company: (i) gives
the Holder prompt notice of each such cause; and (ii) uses reasonable efforts to
correct such failure or delay in its performance.

     (ii) In addition to any other rights available to the Holder, if the Company
fails to cause its transfer agent to transmit to the Holder a certificate or
certificates representing the shares of Common Stock issuable upon exercise of the
Warrant on or before the Share Delivery Date, and if after such date the Holder is
required by its broker to purchase (in an open market transaction or
otherwise) shares of Common Stock to deliver in satisfaction of a
sale by the Holder of the shares of Common Stock issuable upon exercise of the Warrant which the Holder
anticipated receiving upon such exercise (a “BUY-IN”), then the Company shall (1) pay
in cash to the Holder the amount by which (x) the Holder’s total purchase price
(including brokerage commissions, if any) for the shares of Common Stock so purchased
exceeds (y) the amount obtained by multiplying (A) the number of shares of Common
Stock issuable upon exercise of the Warrant that the Company was required to deliver
to the Holder in connection with the conversion at issue times (B) the price at which
the sell order giving rise to such purchase obligation was executed, and (2) at the
option of the Holder, either reinstate the portion of the Warrant and equivalent

53

 

number of shares of Common Stock for which such conversion was not honored or
deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its conversion and delivery obligations
hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted conversion of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation
of $10,000, under clause (1) of the immediately preceding sentence the Company shall
be required to pay the Holder $1,000. The Holder shall provide the Company written
notice indicating the amounts payable to the Holder in respect of the Buy-In,
together with applicable confirmations and other evidence reasonably requested by the
Company. Nothing herein shall limit a Holder’s right to pursue any other remedies
available to it hereunder, at law or in equity including, without limitation, a
decree of specific performance and/or injunctive relief with respect to the Company’s
failure to timely deliver certificates representing shares of Common Stock upon
exercise of the Warrant as required pursuant to the terms hereof.

	3.	 	Stock Fully Paid; Reservation of Shares. All Warrant Shares that may be issued upon
the exercise of the rights represented by this Warrant will, upon issuance pursuant to the
terms and conditions herein, be fully paid and non-assessable, and free from all taxes (other
than any taxes determined with respect to, or based upon, the income of the person to whom
such shares are issued), liens and charges (other than liens or charges created by actions of
the Holder of this Warrant or the person to whom such shares are issued), and pre-emptive
rights with respect to the issue thereof.
	 
	4.	 	Adjustment of Warrant Price and Number of Shares. The number and kind of securities
purchasable upon the exercise of this Warrant and the Warrant Price shall be subject to
adjustment from time to time upon the occurrence of certain events, as follows:

	 	a.	 	Reclassification, Merger or Sale of Assets. In case of any reclassification,
change or conversion of securities of the class issuable upon exercise of this Warrant
(other than a change in par value, or from par value to no par value, or from no par
value to par value, or as a result of a subdivision or combination), or in case of any
merger of the Company with or into another corporation (other than a merger with
another corporation in which the Company is the acquiring and the surviving corporation
and which does not result in any reclassification or change of outstanding securities
issuable upon exercise of this Warrant), or in case of any sale of all or substantially
all of the assets of the Company (each a “Change Event”), the Company shall notify
Holder in writing at least ten (10) days prior to such Change Event, and the Holder
shall have the option to exchange this Warrant into either (i) a new Warrant so that
the Holder of this Warrant shall have the right to receive, at a total purchase price
not to exceed that payable upon the exercise of the unexercised portion of this
Warrant, and in lieu of the shares of Common Stock theretofore issuable upon exercise
of this Warrant, the kind and amount of shares of stock, other securities, money and
property receivable upon such reclassification, change or merger by a holder of the
number of shares of Common Stock then purchasable under this Warrant (such new Warrant
shall provide for adjustments that shall be as nearly equivalent as may be practicable
to the adjustments provided for in this Section 4) or
(ii) in lieu of the shares of Common Stock theretofore issuable upon exercise of this Warrant, the kind and
amount of shares of stock, other securities, money and property receivable by a holder
of the number of shares of Common Stock then purchasable under this Warrant upon such
reclassification, change or merger as if Holder had exercised the unexercised portion
of this Warrant on a cashless exercise basis (as calculated below) immediately prior to
such Change Event.
	 
	 	 	 	For the purpose of determining how many shares of Common Stock Holder would be
entitled to in such a “cashless exercise,” the Holder will be deemed to be entitled
to receive the number of Warrant Shares equal to the quotient obtained by dividing
[(A-B) (X)] by (A), where:

	 	(A)	=	 the VWAP (as defined below) for the 10 Trading Days
immediately preceding the date of such election;
	 
	 	(B)	=	 the Exercise Price of this Warrant, as adjusted; and
	 
	 	(X)	=	 the number of Warrant Shares issuable upon exercise of this
Warrant in accordance with the terms of this Warrant by means of a cash exercise
rather than a cashless exercise.

54

 

	 	 	 	The term “VWAP” means, for any date, the price determined by the first of the
following clauses that applies: (a) if the Common Stock is then listed or quoted on
Nasdaq or any other national securities exchange on which the Common stock is then
listed or quoted (each such exchange, a “Trading Market”), the daily volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on
the Trading Market on which the Common Stock is then listed or quoted as reported by
Bloomberg L.P. (based on a Trading Day from 9:30 a.m. New York City time to 4:02 p.m.
New York City time); (b) if the OTC Bulletin Board is not a Trading Market, the
volume weighted average price of the Common Stock for such date (or the nearest
preceding date) on the OTC Bulletin Board; (c) if the Common Stock is not then listed
or quoted on a Trading Market or the OTC Bulletin Board and if prices for the Common
Stock are then reported in the “Pink Sheets” published by Pink Sheets, LLC (or a
similar organization or agency succeeding to its functions of reporting prices), the
most recent bid price per share of the Common Stock so reported; or (d) in all other
cases, the fair market value of a share of Common Stock as determined by an
independent appraiser selected in good faith by the Holder and reasonably acceptable
to the Company, the fees and expenses of which shall be paid by the Company.
	 
	 	 	 	If the Holder does not notify the Company that it elects to receive the consideration
contemplated by Section 4(a)(ii) in writing prior to the Change Event, the
Holder shall be deemed to have elected to receive a new Warrant as contemplated by
Section 4(a)(i). The provisions of this Section 4(a) shall similarly
apply to successive reclassifications, changes, mergers and transfers.

	 	b.	 	Subdivision or Combination of Shares. If at any time while this Warrant remains
outstanding and unexpired the Company shall subdivide or combine its outstanding shares
of Common Stock, the Warrant Price shall be proportionately decreased in the case of a
subdivision and increased in the case of a combination, effective at the close of
business on the date the subdivision or combination becomes effective.
	 
	 	c.	 	Stock Dividends. If at any time while this Warrant is outstanding and unexpired
the Company shall pay a dividend with respect to Common Stock payable in Common Stock,
then the Warrant Price shall be adjusted, from and after the date of determination of
stockHolders entitled to receive such dividend or distribution, to that price
determined by multiplying the Warrant Price in effect immediately prior to such date of
determination by a fraction (i) the numerator of which shall be
the total number of shares of Common Stock outstanding immediately prior to such dividend, and (ii) the
denominator of which shall be the total number of shares of Common Stock outstanding
immediately after such dividend.
	 
	 	d.	 	Other Issuances of Securities. In case the Company shall, at any time after the
Date of Grant, issue shares of Common Stock, or rights, options, warrants or
convertible or exchangeable securities containing the right to subscribe for or
purchase shares of Common Stock (excluding (i) shares, rights, options, warrants, or
convertible or exchangeable securities issued in any of the transactions described in
Sections 4(a), 4(b), or 4(c) above; (ii) shares issued upon the exercise of any
outstanding rights, options or warrants or upon conversion or exchange of any
outstanding convertible or exchangeable securities; (iii) this Warrant and any shares
issued upon exercise thereof; and (iv) Exempt Securities (as defined in Section 4(l)
below)), at a price per share of Common Stock (determined in the case of such rights,
options, warrants, or convertible or exchangeable securities by dividing (x) the total
amount receivable by the Company in consideration of the sale and issuance of such
rights, options, warrants, or convertible or exchangeable securities, plus the total
minimum consideration payable to the Company upon exercise, conversion, or exchange
thereof by (y) the total maximum number of shares of Common Stock covered by such
rights, options, warrants, or convertible or exchangeable securities) lower than the
Warrant Price, then the Warrant Price shall be reduced, concurrently with such issue,
to a price equal to the consideration received per share in connection with such
issuance. For the purposes of such adjustment, the maximum number of shares of Common
Stock which the Holder of any such rights, options, warrants or convertible or
exchangeable securities shall be entitled to subscribe for or purchase shall be deemed
to be issued and outstanding as of the date of such sale and issuance and the
consideration received by the Company therefore shall be deemed to be the consideration
received by the Company for such rights, options, warrants, or convertible or
exchangeable securities, plus the minimum consideration or premium stated in such
rights, options, warrants, or convertible or exchangeable securities
to be paid for the shares of Common Stock covered thereby. In case the Company shall sell and issue shares
of Common Stock, or rights, options, warrants, or convertible or exchangeable
securities containing the right to subscribe for or purchase shares of Common Stock for
a consideration consisting, in whole or in part, of property other

55

 

	 	 	 	than cash or its equivalent, then, in determining the price per share of Common Stock
and the consideration received by the Company for purposes of the first sentence of
this Section 4(d), the Board of Directors of the Company shall determine, in good
faith, the fair value of said property, and such determination shall be described in
a duly adopted board resolution certified by the Company’s Secretary or Assistant
Secretary. In case the Company shall sell and issue rights, options, warrants, or
convertible or exchangeable securities containing the right to subscribe for or
purchase shares of Common Stock together with one (1) or more other securities as a
part of a unit at a price per unit, then, in determining the price per share of
Common Stock and the consideration received by the Company for purposes of the first
sentence of this Section 4(d), the Board of Directors of the Company shall determine,
in good faith, which determination shall be described in a duly adopted board
resolution certified by the Company’s Secretary or Assistant Secretary, the fair
value of the rights, options, warrants, or convertible or exchangeable securities
then being sold as part of such unit. Such adjustment shall be made successively
whenever such an issuance occurs, and in the event that such rights, options,
warrants, or convertible or exchangeable securities expire or cease to be convertible
or exchangeable before they are exercised, converted, or exchanged (as the case may
be), then the Warrant Price shall again be adjusted to the Warrant Price that would
then be in effect if such sale and issuance had not occurred, but such subsequent
adjustment shall not affect the number of Warrant Shares issued upon any exercise of
the Warrant prior to the date such subsequent adjustment is made.

	 	e.	 	Distribution. If the Company shall declare or make any dividend or other
distribution of its assets (or rights to acquire its assets) to holders of shares of
Common Stock, by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a
dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or
other similar transaction) (a “DISTRIBUTION”), at any time after the issuance of this
Warrant, then, in each such case, the Warrant Price in effect immediately prior to the
close of business on the record date fixed for the determination of holders of shares
of Common Stock entitled to receive the Distribution shall be reduced, effective as of
the close of business on such record date, to a price determined by multiplying such
Warrant Price by a fraction of which (i) the numerator shall be the Warrant Price on
such record date minus the value of the Distribution (as determined in good faith by
the Company’s Board of Directors) applicable to one share of Common Stock, and (ii) the
denominator shall be the Warrant Price on such record date
	 
	 	f.	 	Other Events. If any event occurs of the type contemplated by the provisions of
this Section 4 but not expressly provided for by such provisions (including, without
limitation, the granting of stock appreciation rights, phantom stock rights or other
rights with equity features), then the Company’s Board of Directors in good faith will
make an appropriate adjustment in the Warrant Price so as to be equitable under the
circumstances and otherwise protect the rights of the Holder; provided that no such
adjustment will increase the Warrant Price as otherwise determined pursuant to this
Section 4.

	5.	 	Notice of Adjustments. Whenever the Warrant Price or the number of Warrant Shares
purchasable hereunder shall be adjusted pursuant to Section 4 hereof, the Company
shall deliver to the Holder of this Warrant a certificate signed by its chief financial
officer setting forth, in reasonable detail, the event requiring the adjustment, the amount of
the adjustment, the method by which such adjustment was calculated, and the Warrant Price and
the number of Warrant Shares purchasable hereunder after giving effect to such adjustment.
	 
	6.	 	Fractional Shares. No fractional shares of Common Stock will be issued in connection
with any exercise hereunder, but in lieu of such fractional shares the Company shall make a
cash payment therefor based on the fair market value of a share of Common Stock on the date of
exercise, or round up to the next whole number of shares, at the Company’s option. “FAIR
MARKET VALUE” of a share of Common Stock as of a particular date (the “DETERMINATION DATE”)
shall mean (i) if shares of Common Stock are traded on a national securities exchange (an
“EXCHANGE”), the weighted average of the closing sale price of a share of the Common Stock of
the Company on the last five (5) trading days prior to the Determination Date reported on such
Exchange as reported in The Wall Street Journal (weighted with respect to the trading volume
with respect to each such day); (ii) if shares of Common Stock are not traded on an Exchange
but trade in the over-the-counter market and such shares are quoted on the National
Association of Securities Dealers Automated Quotations System (“NASDAQ”), the weighted average
of the closing sale price of a share of the Common Stock of the Company on the last five (5)
trading days prior to the Determination Date reported on NASDAQ as reported in The Wall Street
Journal (weighted with respect to the trading volume with respect to each such day); (iii) if
such shares are an issue for

56

 

	 	 	which last sale prices are not reported on NASDAQ, the average of the closing sale price, in
each case on the last five (5) trading days (or if the relevant price or quotation did not
exist on any of such days, the relevant price or quotation on the next preceding business
day on which there was such a price or quotation) prior to the Determination Date as
reported by the Over the Counter Bulletin Board (the “OTCBB”), the National Quotation
Bureau, Incorporated, or any other successor organization; (iv) if no closing sales price is
reported for the Common Stock by the OTCBB, National Quotation Bureau, Incorporated or any
other successor organization for such day, the average of the high and low bid and asked
price of any of the market makers for the Common Stock as reported on the OTCBB or in the
“pink sheets” by the Pink Sheets, LLC on the last five (5) trading days; or (v) if no price
can be determined on the basis of the above methods of valuation, then the Fair Market Value
shall be determined in good faith by the Board of Directors of the Company, which
determination shall be described in a duly adopted board resolution certified by the
Company’s Secretary or Assistant Secretary. If the Board of Directors of the Company is
unable to determine the Fair Market Value, or if the Holders of at least fifty percent (50%)
of all of the Warrant Shares then issuable hereunder (collectively, the “REQUESTING
HOLDERS”) disagree with the Board’s determination of the Fair Market Value by written notice
delivered to the Company within five (5) business days after the determination thereof by
the Board of Directors of the Company is communicated to Holders of the Warrants affected
thereby, which notice specifies a majority-in-interest of the Requesting Holders’
determination of the Fair Market Value, then the Company and a majority-in-interest of the
Requesting Holders shall select a mutually acceptable investment banking firm of national
reputation which has not had a material relationship with the Company or any officer of the
Company within the preceding two (2) years, which shall determine the Fair Market Value.
Such investment banking firm’s determination of the Fair Market Value shall be final,
binding and conclusive on the Company and the Holders of all of the Warrants issued
hereunder and then outstanding. Any and all costs and fees of such investment banking firm
shall be borne equally by the Company and the Requesting Holders, however, if the Valuation
is within ninety percent (90%) of either party’s valuation, then the other party shall pay
all of the costs and fees of such investment banking firm.
	 
	7.	 	Noncircumvention. The Company hereby covenants and agrees that the Company will not, by
amendment of its Certificate of Incorporation, Bylaws or through any reorganization, transfer
of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of
securities, or any other voluntary action, avoid or seek to avoid the observance or
performance of any of the terms of this Warrant, and will at all times in good faith carry out
all the provisions of this Warrant and take all action as may be required to protect the
rights of the Holder. Without limiting the generality of the foregoing, the Company (i) shall
not increase the par value of any shares of Common Stock receivable upon the exercise of this
Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be
necessary or appropriate in order that the Company may validly and legally issue fully paid
and nonassessable shares of Common Stock upon the exercise of this Warrant, and (iii) shall,
so long as any of the Warrants are outstanding, take all action necessary to reserve and keep
available out of its authorized and unissued shares of Common Stock, solely for the purpose of
effecting the exercise of the Warrants, 100% of the number of shares of Common Stock as shall
from time to time be necessary to effect the exercise of the Warrants then outstanding
(without regard to any limitations on exercise).
	 
	9.	 	Rights as Stockholders; Information. No Holder of this Warrant, as such, shall be
entitled to vote or be deemed the Holder of Common Stock or any other securities of the
Company which may at any time be issuable on the exercise hereof for any purpose, nor shall
anything contained herein be construed to confer upon the Holder of this Warrant, as such, any
of the rights of a stockholder of the Company or any right to vote for the election of the
directors or upon any matter submitted to stockholders at any meeting thereof, or to receive
notice of meetings, until this Warrant shall have been exercised and the Warrant Shares
purchasable upon the exercise hereof shall have become deliverable, as provided herein.
	 
	10.	 	Modification and Waiver. This Warrant and any provision hereof may be changed,
waived, discharged or terminated only by an instrument in writing signed by the party against
which enforcement of the same is sought
	 
	11.	 	Notices. Unless otherwise specifically provided herein, all communications under this
Warrant shall be in writing and shall be deemed to have been duly given (i) on the date of
service if served personally on the party to whom notice is to be given; (ii) on the day of
transmission if sent by facsimile transmission to the number shown on the books of the
Company, and telephonic confirmation of receipt is obtained promptly after completion of
transmission; (iii) on the day after delivery to Federal Express or similar overnight courier;
or (iv) on the fifth day after mailing, if mailed to the party to whom notice is to be given,
by first class mail, registered or certified, postage prepaid, and properly addressed, return
receipt requested, to each such Holder at its address as shown on the books of the Company or
to the Company

57

 

	 	 	at the address indicated therefor on the signature page of this Warrant. Any party hereto may
change its address for purposes of this Section by giving the other party written notice of the
new address in the manner set forth herein.
	 
	12.	 	Binding Effect on Successors. This Warrant shall be binding upon any corporation
succeeding the Company by merger, consolidation or acquisition of all or substantially all of
the Company’s assets, and all of the obligations of the Company relating to the Common Stock
issuable upon the exercise or conversion of this Warrant shall survive the exercise,
conversion and termination of this Warrant and all of the covenants and agreements of the
Company shall inure to the benefit of the successors and assigns of the Holder hereof. The
Company will, at the time of the exercise or conversion of this Warrant, in whole or in part,
upon request of the Holder hereof but at the Company’s expense, acknowledge in writing its
continuing obligation to the Holder hereof in respect of any rights to which the Holder hereof
shall continue to be entitled after such exercise or conversion in accordance with this
Warrant; provided, however, that the failure of the Holder hereof to make any such request
shall not affect the continuing obligation of the Company to the Holder hereof in respect of
such rights.
	 
	13.	 	Lost Warrants or Stock Certificates. The Company covenants to the Holder hereof that,
upon receipt of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant or any stock certificate and, in the case of any
loss, theft or destruction, upon receipt of an executed lost securities bond or indemnity
reasonably satisfactory to the Company, or in the case of any such mutilation upon surrender
and cancellation of such Warrant or stock certificate, the Company will make and deliver a new
Warrant or stock certificate, of like tenor, in lieu of the lost, stolen, destroyed or
mutilated Warrant or stock certificate.
	 
	14.	 	Descriptive Headings. The descriptive headings of the several paragraphs of this
Warrant are inserted for convenience only and do not constitute a part of this Warrant.
	 
	15.	 	Governing Law. This Warrant shall be construed and enforced in accordance with, and
the rights of the parties shall be governed by, the laws of the State of Florida.
	 
	16.	 	Remedies. In case any one (1) or more of the covenants and agreements contained in
this Warrant shall have been breached, the Holders hereof (in the case of a breach by the
Company), or the Company (in the case of a breach by a Holder), may proceed to protect and
enforce their or its rights either by suit in equity and/or by action at law, including, but
not limited to, an action for damages as a result of any such breach and/or an action for
specific performance of any such covenant or agreement contained in this Warrant.
	 
	17.	 	Acceptance. Receipt of this Warrant by the Holder hereof shall constitute acceptance
of and agreement to the foregoing terms and conditions.
	 
	18.	 	No Impairment of Rights. The Company will not, by amendment of its Certificate of
Incorporation or through any other means, avoid or seek to avoid the observance or performance
of any of the terms of this Warrant, but will at all times in good faith assist in the
carrying out of all such terms and in the taking of all such action as may be necessary or
appropriate in order to protect the rights of the Holder of this Warrant against impairment.

[SIGNATURE PAGE FOLLOWS]

58

 

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed on its behalf by one of its
officers thereunto duly authorized.

	 	 	 	 	 
	BROOKSIDE TECHNOLOGY HOLDINGS CORP.

 	 	 
	
 	 	 
	Michael Nole, Chief Executive Officer 	 	 
	 	 	 

Dated: April 12, 2010

59

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}]]